Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Sage Therapeutics Inc. logo

Sage Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

11.27
 
USD
  
-0.73
  
(-6.08%)
Optionable: Yes  Market Cap: 638 M  90-day average vol: 1,194,417

Previous close: 12.0  Open: 11.87  Bid: 11.0  Ask: 12.14
52 week range    
9.76   
   56.37
Last updated: Tuesday 18th June 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

SAGE Cash Flow

Annual
Invalid dateDec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
(Increase) Decrease in other current assets-165000.0
(Increase) Decrease in other current liabilities-21000.0
(Increase) Decrease in other working capital-4 M452000.0-910000.0-519000.0
(Increase) Decrease in payables441000.03 M8 M-4 M25 M-19 M-12 M7 M8 M
(Increase) Decrease in receivables-19 M5 M
CapitalExpenditureReported128000.0198000.01 M1 M3 M6 M345000.0372000.0937000.0
Cash at beginning of period8 M128 M187 M169 M307 M193 M129 M1,663 M296 M
Cash at end of period181 M187 M169 M307 M193 M129 M1,663 M296 M164 M
Cash flow-27 M-71 M-119 M-219 M-261 M-529 M664 M-378 M-460 M
CashFlowFromContinuingInvestingActivities-128000.0-198000.0-231 M15 M-512 M-143 M443 M-1,002 M325 M
ChangeInAccountPayable441000.03 M8 M-4 M25 M-19 M-12 M7 M8 M
ChangeInAccruedExpense4 M5 M13 M20 M10 M34 M-32 M12 M5 M
ChangeInInterestPayable4 M5 M13 M20 M10 M
ChangeInPayablesAndAccruedExpense5 M8 M21 M16 M35 M15 M-44 M18 M13 M
ChangeInPrepaidAssets-715000.0-681000.0-3 M-1 M-15 M-5 M4 M-17 M-11 M
ChangeInWorkingCapital4 M7 M17 M15 M19 M6 M-39 M-18 M6 M
ChangesInAccountReceivables-19 M5 M
Depreciation51000.0115000.0281000.0531000.01 M2 M3 M4 M1 M
Depreciation unreconciled51000.0115000.0281000.0531000.01 M2 M3 M4 M1 M
DepreciationAndAmortization51000.0115000.0281000.0531000.01 M2 M3 M4 M1 M
FinancingCashFlow200 M130 M331 M342 M659 M608 M427 M13 M3 M
Free cash flow-27 M-71 M-120 M-221 M-264 M-534 M664 M-379 M-461 M
GainLossOnInvestmentSecurities-7 M1 M13 M6 M
Issuance of capital stock96 M130 M330 M326 M631 M561 M
IssuanceOfCapitalStock96 M130 M330 M326 M631 M561 M
Net cash from financing activities200 M130 M331 M342 M659 M608 M427 M13 M3 M
Net cash from investing activities-128000.0-198000.0-231 M15 M-512 M-143 M443 M-1,002 M325 M
Net cash from operating activities-27 M-71 M-119 M-219 M-261 M-529 M664 M-378 M-460 M
Net change in cash & cash equivalents173 M59 M-18 M138 M-114 M-64 M1,534 M-1,367 M-132 M
Net income from continuing operations-34 M-94 M-159 M-270 M-373 M-680 M606 M-458 M-533 M
NetCommonStockIssuance96 M130 M330 M326 M631 M561 M
NetInvestmentPropertiesPurchaseAndSale-229 M17 M-510 M-137 M443 M-1,002 M326 M
NetInvestmentPurchaseAndSale-229 M17 M-510 M-137 M443 M-1,002 M326 M
NetPPEPurchaseAndSale-128000.0-198000.0-1 M-1 M-3 M-6 M-345000.0-372000.0-937000.0
NetPreferredStockIssuance106 M
Operating (gains) losses-7 M1 M13 M6 M
Other financing charges net-2 M-584000.0-599000.0-179000.0-1 M-3 M418 M-1 M-43000.0
Other investing changes net-525000.0-285000.0
Other non-cash items3 M16 M23 M35 M92 M150 M94 M80 M59 M
PreferredStockIssuance106 M
ProceedsFromStockOptionExercised40000.0730000.01 M16 M29 M49 M9 M15 M3 M
Purchase of Float term investments-259 M-244 M-1,484 M-1,309 M-459 M-1,990 M-881 M
Purchase of property plant & equipment-128000.0-198000.0-1 M-1 M-3 M-6 M-345000.0-372000.0-937000.0
PurchaseOfInvestment-259 M-244 M-1,484 M-1,309 M-459 M-1,990 M-881 M
PurchaseOfPPE-128000.0-198000.0-1 M-1 M-3 M-6 M-345000.0-372000.0-937000.0
Revenue per share286000.0
Sale of short term investments30 M261 M975 M1,171 M902 M988 M1,207 M
SaleOfInvestment30 M261 M975 M1,171 M902 M988 M1,207 M
StockBasedCompensation3 M15 M23 M36 M102 M153 M96 M105 M62 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University